在大规模分发阿奇霉素治疗沙眼后，沙眼衣原体未出现大环内酯类耐药性。
Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma.
作者信息
Hong Kevin Cyrus, Schachter Julius, Moncada Jeanne, Zhou Zhaoxia, House Jenafir, Lietman Thomas M
机构信息
University of California, San Francisco, California 94143, USA.
出版信息
Emerg Infect Dis. 2009 Jul;15(7):1088-90. doi: 10.3201/eid1507.081563.
Abstract
We investigated antimicrobial drug resistance in ocular Chlamydia trachomatis 18 months after 4 biannual communitywide distributions of antimicrobial drugs in a region of Ethiopia where ocular strains of C. trachomatis are highly endemic. We found no significant differences in susceptibilities to azithromycin and doxycycline in 6 posttreatment and 4 pretreatment samples.
摘要
在埃塞俄比亚沙眼衣原体眼部菌株高度流行的一个地区，每半年进行一次全社区抗菌药物分发，共进行了4次。18个月后，我们调查了眼部沙眼衣原体的抗菌药物耐药性。我们发现，6份治疗后样本和4份治疗前样本对阿奇霉素和强力霉素的敏感性没有显著差异。
相似文献
1
Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma.在大规模分发阿奇霉素治疗沙眼后，沙眼衣原体未出现大环内酯类耐药性。
Emerg Infect Dis. 2009 Jul;15(7):1088-90. doi: 10.3201/eid1507.081563.
2
Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial.在埃塞俄比亚沙眼流行地区大规模分发阿奇霉素治疗眼部衣原体感染的频率：一项整群随机试验。
Am J Ophthalmol. 2020 Jun;214:143-150. doi: 10.1016/j.ajo.2020.02.019. Epub 2020 Apr 17.
3
Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).大规模阿奇霉素分发用于流行地区沙眼的随机对照试验后：重新随机分组的亚组的延续研究（TANA II）。
PLoS Med. 2018 Aug 14;15(8):e1002633. doi: 10.1371/journal.pmed.1002633. eCollection 2018 Aug.
4
A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.大规模阿奇霉素分发后衣原体感染和沙眼性炎症的纵向分析
Ophthalmic Epidemiol. 2019 Feb;26(1):19-26. doi: 10.1080/09286586.2018.1512635. Epub 2018 Aug 28.
5
Population-Based Prevalence of Ocular Chlamydia trachomatis Infection among Infants in the Trachoma Endemic Amhara Region, Ethiopia.基于人群的埃塞俄比亚塔克洛腊流行地区婴儿眼型沙眼衣原体感染的患病率。
Am J Trop Med Hyg. 2021 Oct 25;106(1):62-65. doi: 10.4269/ajtmh.21-0873.
6
Stopping azithromycin mass drug administration for trachoma: A systematic review.停止阿奇霉素群体药物治疗沙眼：系统评价。
PLoS Negl Trop Dis. 2021 Jul 8;15(7):e0009491. doi: 10.1371/journal.pntd.0009491. eCollection 2021 Jul.
7
Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, Ethiopia.埃塞俄比亚阿姆哈拉地区 SAFE 干预沙眼 5 年后眼部沙眼衣原体的基因组学研究
J Infect Dis. 2022 Mar 15;225(6):994-1004. doi: 10.1093/infdis/jiaa615.
8
Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review.大规模阿奇霉素分配用于沙眼后的抗微生物药物耐药性：系统评价。
Lancet Infect Dis. 2019 Jan;19(1):e14-e25. doi: 10.1016/S1473-3099(18)30444-4. Epub 2018 Oct 3.
9
Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis.阿奇霉素质量分布对眼部沙眼衣原体抗生素敏感性的影响。
Antimicrob Agents Chemother. 2005 Nov;49(11):4804-6. doi: 10.1128/AAC.49.11.4804-4806.2005.
10
Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?大规模沙眼控制治疗后，眼衣原体对阿奇霉素的耐药性是否有证据？
J Infect Dis. 2014 Jul 1;210(1):65-71. doi: 10.1093/infdis/jiu046. Epub 2014 Jan 19.
引用本文的文献
1
The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children.沙眼控制中阿奇霉素群体药物治疗前后坦桑尼亚儿童结膜微生物组的变化。
Front Public Health. 2022 Oct 17;10:1015714. doi: 10.3389/fpubh.2022.1015714. eCollection 2022.
2
Trachoma.沙眼。
Nat Rev Dis Primers. 2022 May 26;8(1):32. doi: 10.1038/s41572-022-00359-5.
3
Chlamydial clinical isolates show subtle differences in persistence phenotypes and growth .衣原体临床分离株在持续存在表型和生长方面表现出细微差异。
Access Microbiol. 2021 Feb 19;3(3):000204. doi: 10.1099/acmi.0.000204. eCollection 2021 Mar.
4
Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, Ethiopia.埃塞俄比亚阿姆哈拉地区 SAFE 干预沙眼 5 年后眼部沙眼衣原体的基因组学研究
J Infect Dis. 2022 Mar 15;225(6):994-1004. doi: 10.1093/infdis/jiaa615.
5
Whole-genome sequencing of ocular Chlamydia trachomatis isolates from Gadarif State, Sudan.对来自苏丹加达里夫州的眼部沙眼衣原体分离株进行全基因组测序。
Parasit Vectors. 2019 Nov 4;12(1):518. doi: 10.1186/s13071-019-3770-7.
6
Antibiotics for trachoma.用于沙眼的抗生素。
Cochrane Database Syst Rev. 2019 Sep 26;9(9):CD001860. doi: 10.1002/14651858.CD001860.pub4.
7
Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).大规模阿奇霉素分发用于流行地区沙眼的随机对照试验后：重新随机分组的亚组的延续研究（TANA II）。
PLoS Med. 2018 Aug 14;15(8):e1002633. doi: 10.1371/journal.pmed.1002633. eCollection 2018 Aug.
8
Models of Trachoma Transmission and Their Policy Implications: From Control to Elimination.沙眼传播模型及其政策意义：从控制到消除。
Clin Infect Dis. 2018 Jun 1;66(suppl_4):S275-S280. doi: 10.1093/cid/ciy004.
9
Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.大规模发放阿奇霉素后儿童死亡率：尼日尔 PRET 集群随机试验的二次分析。
Pediatr Infect Dis J. 2018 Nov;37(11):1082-1086. doi: 10.1097/INF.0000000000001992.
10
Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control.在使用阿奇霉素进行大规模药物给药以控制沙眼后，耐大环内酯类金黄色葡萄球菌鼻咽部携带率的短期上升。
BMC Microbiol. 2017 Mar 28;17(1):75. doi: 10.1186/s12866-017-0982-x.
本文引用的文献
1
Reduction and return of infectious trachoma in severely affected communities in Ethiopia.在埃塞俄比亚受影响严重的社区中减少和消除传染性沙眼。
PLoS Negl Trop Dis. 2009;3(2):e376. doi: 10.1371/journal.pntd.0000376. Epub 2009 Feb 3.
2
Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.单次大规模抗生素分发对感染性沙眼患病率的影响。
JAMA. 2006 Mar 8;295(10):1142-6. doi: 10.1001/jama.295.10.1142.
3
Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis.阿奇霉素质量分布对眼部沙眼衣原体抗生素敏感性的影响。
Antimicrob Agents Chemother. 2005 Nov;49(11):4804-6. doi: 10.1128/AAC.49.11.4804-4806.2005.
4
Fitness cost due to mutations in the 16S rRNA associated with spectinomycin resistance in Chlamydia psittaci 6BC.鹦鹉热衣原体6BC中与壮观霉素抗性相关的16S rRNA突变导致的适应性代价。
Antimicrob Agents Chemother. 2005 Nov;49(11):4455-64. doi: 10.1128/AAC.49.11.4455-4464.2005.
5
Global data on visual impairment in the year 2002.2002年全球视力损害数据。
Bull World Health Organ. 2004 Nov;82(11):844-51. Epub 2004 Dec 14.
6
Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp.用于衣原体属抗菌药敏试验的方法和细胞系
Antimicrob Agents Chemother. 2003 Feb;47(2):636-42. doi: 10.1128/AAC.47.2.636-642.2003.
7
Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.阿奇霉素群体给药消除尼泊尔沙眼致盲的不良和有益副作用
Clin Infect Dis. 2002 Aug 15;35(4):395-402. doi: 10.1086/341414. Epub 2002 Jul 23.
8
Chlamydial genovar distribution after community wide antibiotic treatment.社区范围抗生素治疗后的衣原体基因变种分布。
J Infect Dis. 2001 Dec 15;184(12):1581-8. doi: 10.1086/324661. Epub 2001 Dec 3.
9
Azithromycin in control of trachoma.阿奇霉素用于控制沙眼
Lancet. 1999 Aug 21;354(9179):630-5. doi: 10.1016/S0140-6736(98)12387-5.
10
A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae.一项关于社区沙眼阿奇霉素治疗对肺炎链球菌携带及耐药性影响的前瞻性研究。
Clin Infect Dis. 1997 Mar;24(3):356-62. doi: 10.1093/clinids/24.3.356.
Zotero 插件